- Glenmark Pharmaceuticals on June 22 announced the launch of antiviral drug Favipiravir — under its brand name FabiFlu — for the treatment of mild to moderate COVID-19 patients.
- Cipla and Hetero introduced the Remdesivir “the most promising candidate” for treating the novel coronavirus.
- These drugs were originally designed to treat other diseases like any skin disease or arthritis but now their generic version is introduced to treat coronavirus patients.
There is some good news for Indians — medicines showing promising results to treat coronavirus. India’s pharmaceutical companies like Glenmark, Hetero Drugs, and Cipla have repurposed at least five drugs that might help treat coronavirus patients.
These drugs were originally designed to treat other diseases like any skin disease or arthritis but now their generic version is introduced to treat coronavirus patients. The news comes at a time when the novel coronavirus has infected over 4 lakh people in the country and killed over 15,000.